Landmark Clinical Trial Results in First FDA-Approved Treatment for Rare Form of Obesity Caused by Brain Injury
July 11: Children and adults living with a rare condition that causes rapid, uncontrollable weight gain now have a new…
You Daily Dose of Sports News
July 11: Children and adults living with a rare condition that causes rapid, uncontrollable weight gain now have a new…
Guwahati, July 10: The Assam government has presented a budget focused on employment generation, infrastructure development, healthcare improvement, and overall…
New Delhi, July 10: The government has announced that formulations containing high levels of alcohol will require appropriate licences and…
Chandigarh, July 10: Monsoon hair concerns are often less about the weather itself and more about the way people respond to it. Monsoon demands smarter…
July, 9: Gritzo, a science-backed personalized children’s nutrition brand, has unveiled its flagship campaign for 2026, ‘Protein Ki Zimmedari Hamari, taking…
Milan, Italy, July 08 — Genespire, in collaboration with researchers at the San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), has today announced the publication of preclinical data supporting the potential of its liver-directed immune-shielded lentiviral gene therapy approach to treat methylmalonic acidemia (MMA), a severe inherited metabolic disorder. The findings, published in the Journal of Hepatology, show that a single systemic administration of a lentiviral vector encoding the MMUT gene led to sustained improvements in disease features in a validated mouse model of MMA, with effects lasting for the average lifespan of laboratory mice. Since the mice were treated when young, the study supports the durability of the gene therapy through postnatal growth and maturation of the liver. MMA is caused by a deficiency of methylmalonyl-CoA mutase, an enzyme that plays a critical role in the body’s metabolism of food. Its absence results in the accumulation of toxic metabolites that lead to recurrent metabolic crises, growth failure, neurological impairment, and multi-organ damage. In the study, researchers also treated mice with a dose containing an optimized MMUT transgene, thereby improving therapeutic efficacy. In the same mouse model of MMA, this…
Bhopal, July 8: The Madhya Pradesh Government is working to expand digital healthcare services to the remotest parts of the…
New Delhi, July 08: Patients across Delhi and North India suffering from persistent dizziness, vertigo and balance disorders will no longer need to travel across the country for specialised…
Lucknow, July 8: The Uttar Pradesh government has launched a new cashless healthcare scheme aimed at providing easier and more…
New Delhi, July 8: The Government has approved Navi Mumbai International Airport as an authorised point for importing medicines into…